Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Molecular Profiles’ Innovative Drug Development Services Win Queen’s Award for Enterprise 2011

Abstract:
Molecular Profiles, a leading pharmaceutical development service provider, today announced that it has been awarded a Queen's Award for Enterprise 2011 in the Innovation category for its nanoPASS™ (nanoscale Predictive Analytical Screening Solution) service platform. This novel analytical approach improves the development of new pharmaceuticals by exploiting the latest advances in nanotechnology to yield key analytical data from minute quantities of potential drug candidates and then predicting those candidates that are most likely to make it to market. It helps customers to substantially reduce R&D and production costs and enables earlier introduction of new medicines to market benefiting both industry and patients.

Molecular Profiles’ Innovative Drug Development Services Win Queen’s Award for Enterprise 2011

Nottingham, UK | Posted on April 21st, 2011

The Queen's Award for Enterprise is the most prestigious and widely recognised accolade for UK industry. The Innovation category recognises companies that have demonstrated spectacular commercial success through innovative products or services. Following a 2007 Queen's Award for Continuous Innovation and Development, the 2011 award honours Molecular Profiles for the creation of cutting-edge development services that significantly improve and speed-up the introduction of new drugs.

The nanoPASS service platform uses new analytical approaches to yield key physical and chemical data from minute quantities of many possible drug candidates. Critically this allows clients to predict the potential of each candidate to be manufactured into a medicine at an earlier time than has previously been possible. Prior to this unique solution, prediction analyses were made through iterative research and bulk testing of drug substance. These methods can be expensive and require large amounts of drug substance which is usually not available at early development stages. NanoPASS delivers predictions faster and at an earlier stage.

Molecular Profiles offers a complete portfolio of drug development services including formulation development, preformulation, polymorph screening, salt selection, analytical services and clinical trial manufacturing for up to phase IIa. This extensive range of solutions all under one roof decreases the need to perform a technical transfer of work to other companies and therefore lessens the risk to the customer's research.

Nikin Patel, PhD MRPharmS, CEO of Molecular Profiles, commented, "We are very pleased that our innovative approach has been recognised by the Queen's Award for Enterprise 2011. This great success could not be achieved without the expertise of our team. This accolade recognises their commitment and ability to solve some of the toughest drug development issues."

####

About Molecular Profiles
Molecular Profiles was founded in 1997 by a group of pharmaceutical scientists specialising in advanced characterisation of pharmaceutical and biological materials. Since then, the company has achieved a unique global position in pharmaceutical R&D and developed a wide portfolio of clients including major pharmaceutical companies. With a highly expert scientific team and complete range of services from formulation development to clinical trial manufacturing, Molecular Profiles is ideally placed to offer its clients a range of targeted solutions and help them to overcome the most challenging issues in drug development.

For more information, please click here

Contacts:
Molecular Profiles

Dr. Nikin Patel
+44 115 8718888

For further press information please contact:
Fiona Robinson
The Scott Partnership
1 Whiteside, Station Road
Holmes Chapel, Cheshire, CW4 8AA, United Kingdom
Tel: + 44 1477 539 539
Fax: +44 1477 539 540
E-mail:

Copyright © Molecular Profiles

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

A new, tunable device for spintronics: An international team of scientists including physicist Jairo Sinova from the University of Mainz realises a tunable spin-charge converter made of GaAs August 29th, 2014

Nanoscale assembly line August 29th, 2014

New analytical technology reveals 'nanomechanical' surface traits August 29th, 2014

New Vice President Takes Helm at CNSE CMOST: Catherine Gilbert To Lead CNSE Children’s Museum of Science and Technology Through Expansion And Relocation August 29th, 2014

Nanomedicine

Nanoscale assembly line August 29th, 2014

Copper shines as flexible conductor August 29th, 2014

Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices August 28th, 2014

PetLife Comments on CNN Story on Scorpion Venom Health Benefits August 27th, 2014

Announcements

A new, tunable device for spintronics: An international team of scientists including physicist Jairo Sinova from the University of Mainz realises a tunable spin-charge converter made of GaAs August 29th, 2014

Nanoscale assembly line August 29th, 2014

New analytical technology reveals 'nanomechanical' surface traits August 29th, 2014

New Vice President Takes Helm at CNSE CMOST: Catherine Gilbert To Lead CNSE Children’s Museum of Science and Technology Through Expansion And Relocation August 29th, 2014

Grants/Awards/Scholarships/Gifts/Contests/Honors/Records

Rice physicist emerges as leader in quantum materials research: Nevidomskyy wins both NSF CAREER Award and Cottrell Scholar Award August 20th, 2014

Oxford Instruments Asylum Research Receives the 2014 Microscopy Today Innovation Award for blueDrive Photothermal Excitation August 18th, 2014

AQUANOVA receives Technology Leadership Award 2014 FROST & SULLIVAN honors NovaSOL® Technology again August 12th, 2014

Focal blood-brain-barrier disruption with high-frequency pulsed electric fields August 12th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE